APPLICATION
ANDA200290
TYPE
ANDA
ORIGINAL APPROVAL
2013-08-30
LATEST ACTION
2025-08-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LOSARTAN POTASSIUMDiscontinued
LOSARTAN POTASSIUM 50MG · TABLET · ORAL
LOSARTAN POTASSIUMDiscontinued
LOSARTAN POTASSIUM 100MG · TABLET · ORAL
LOSARTAN POTASSIUMDiscontinued
LOSARTAN POTASSIUM 25MG · TABLET · ORAL
Approval history
2025-08-18Labeling · Supplement 7 · standardAP
2022-07-01Labeling · Supplement 6 · standardAP
2019-09-03Labeling · Supplement 4 · standardAP
2019-09-03Labeling · Supplement 3 · standardAP
2015-02-13Labeling · Supplement 2 · standardAP
2014-11-05Labeling · Supplement 1 · standardAP
2013-08-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.